1. Kovács G, Martinez-Monge R, Budrukkar A et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update – Improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol 2017; 122: 248-254.
2.
Li Y, Jiang Y, Qiu B et al. Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review. J Transl Med 2022; 20: 566.
3.
Budrukkar A, Guinot JL, Tagliaferri L et al. Function preservation in head and neck cancers. Clin Oncol (R Coll Radiol) 2023; 35: 497-506.
4.
Tricco AC, Lillie E, Zarin W et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018; 169: 467-473.
5.
Khalil H, Peters MD, Tricco AC et al. Conducting high quality scoping reviews-challenges and solutions. J Clin Epidemiol 2021; 130: 156-160.
6.
Hancock B. Trent focus for research and development in primary health care: An introduction to qualitative research. Trent Focus, Nottingham 1998: 1-24.
7.
Lee A, Givi B, Wu SP et al. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort. Brachytherapy 2017; 16: 1205-1212.
8.
Zhang M, Zhang J, Hu B et al. The efficacy and safety of 125I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer. Front Oncol 2022; 12: 992399.
9.
Zhao G, Wang Z, Li C et al. A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy. J Contemp Brachytherapy 2022; 14: 519-526.
10.
Zhong YW, Lyu XM, Shi Y et al. Long-term result of 125 I seed brachytherapy for pediatric desmoid tumor in the head and neck. Pediatr Blood Cancer 2023; 70: e30037.
11.
Konishi M, Fujita M, Takeuchi Y et al. Treatment outcomes of real-time intraoral sonography-guided implantation technique of 198Au grain brachytherapy for T1 and T2 tongue cancer. J Radiat Res (Tokyo) 2021; 62: 871-876.
12.
Huang MW, Wu WJ, Lv XM et al. The role of 125I interstitial brachytherapy for inoperable parotid gland carcinoma. Brachytherapy 2018; 17: 244-249.
13.
Li J, Zhang J, Lyu XM et al. Efficacy of surgery combined with postoperative 125 I interstitial brachytherapy for treatment of acinic cell carcinoma of the parotid gland in children and adolescents. Pediatr Blood Cancer 2020; 67: e28343.
14.
Ma YQ, Zheng L, Huang MW et al. Surgery combined with 125I brachytherapy for treatment of carcinoma ex pleomorphic adenoma of the parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol 2021; 131: 395-404.
15.
Mao MH, Zheng L, Wang XM et al. Surgery combined with postoperative 125I seed brachytherapy for the treatment of mucoepidermoid carcinoma of the parotid gland in pediatric patients. Pediatr Blood Cancer 2017; 64: 57-63.
16.
Wu ZY, Wu WJ, Zheng L et al. Efficacy of combined surgery and 125I seed brachytherapy for treatment of primary mucoepidermoid carcinoma of the parotid gland. Head Neck 2019; 41: 3219-3225.
17.
Zhou C, Zhang J, Zhang JG et al. Iodine-125 brachytherapy alone for advanced primary parotid gland carcinoma. Int J Oral Maxillofac Surg 2018; 47: 561-567.
18.
Wu WJ, Shao X, Huang MW et al. Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins. Head Neck 2017; 39: 572-577.
19.
Breen W, Kelly J, Park HS et al. Permanent interstitial brachytherapy for previously irradiated head and neck cancer. Cureus 2018; 10: e2517.
20.
Chen Y, Jiang Y, Ji Z et al. Efficacy and safety of CT-guided 125I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma after surgery and external beam radiotherapy: A 12-year study at a single institution. Brachytherapy 2020; 19: 81-89.
21.
Jiang Y, Ji Z, Guo F et al. Side effects of CT-guided implantation of 125I seeds for recurrent malignant tumors of the head and neck assisted by 3D printing non co-planar template. Radiat Oncol 2018; 13: 18.
22.
Jiang P, Wang J, Ran W et al. Five-year outcome of ultrasound-guided interstitial permanent 125I seeds implantation for local head and neck recurrent tumors: a single center retrospective study. J Contemp Brachytherapy 2019; 11: 28-34.
23.
Jiang Y, Zhen P, Dai J et al. Long-term safety and efficacy of CT-guided I125 radioactive seed implantation as a salvage therapy for recurrent head and neck squamous carcinoma: A multicenter retrospective study. Front Oncol 2021; 11: 645077.
24.
Li Y, Jiang Y, Wang J. Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy. Radiat Oncol 2023; 18: 73.
25.
Kharouta M, Zender C, Podder T et al. Permanent interstitial cesium-131 brachytherapy in treating high-risk recurrent head and neck cancer: A prospective pilot study. Front Oncol 2021; 11: 639480.
26.
Luginbuhl A, Calder A, Kutler D et al. Multi-institutional study validates safety of intraoperative cesium-131 brachytherapy for treatment of recurrent head and neck cancer. Front Oncol 2021; 11: 786216.
27.
Walsh A, Hubley E, Doyle L et al. Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer. J Contemp Brachytherapy 2019; 11: 221-226.
28.
Potharaju M, Raj HE, Muthukumaran M et al. Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer. J Contemp Brachytherapy 2018; 10: 64-72.
29.
Khan N, Clemens M, Liu J et al. The role of salvage surgery with interstitial brachytherapy for the management of regionally recurrent head and neck cancers. Cancers Head Neck 2019; 4: 4.
30.
Martínez-Fernández MI, Alcalde J, Cambeiro M et al. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study. Radiother Oncol J Eur Soc Ther Radiol Oncol 2017; 122: 255-259.
31.
Choi CH, Park SY, Park JM et al. Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy. PLoS One 2018; 13: e0205229.
32.
Cawston-Grant B, Morrison H, Sloboda RS et al. Experimental assessment of the Advanced Collapsed-cone Engine for scalp brachytherapy treatments. Brachytherapy 2018; 17: 489-499.
33.
Agarwal A, Pinto J, Renslo B et al. Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancer. Brachytherapy 2023; 22: 120-124.
34.
Bacorro WR, Agas RAF, Cabrera SMR et al. A novel applicator design for intracavitary brachytherapy of the nasopharynx: Simulated reconstruction, image-guided adaptive brachytherapy planning, and dosimetry. Brachytherapy 2018; 17: 709-717.
35.
Choi CH, Kim JI, Park JM. A 3D-printed patient-specific applicator guide for use in high-dose-rate interstitial brachytherapy for tongue cancer: A phantom study. Phys Med Biol 2019; 64: 135002.
36.
Qiu B, Jiang Y, Ji Z et al. The accuracy of individualized 3D-printing template-assisted I125 radioactive seed implantation for recurrent/metastatic head and neck cancer. Front Oncol 2021; 11: 664996.
37.
Liang Y, Wang Z, Zhang H et al. Three-dimensional-printed individual template-guided 125I seed implantation for the cervical lymph node metastasis: A dosimetric and security study. J Cancer Res Ther 2018; 14: 30-35.
38.
Zwierzchowski G, Bielęda G, Szymbor A et al. Personalized superficial HDR brachytherapy-dosimetric verification of dose distribution with lead shielding of critical organs in the head and neck region. J Pers Med 2022; 12: 1432.
